JP Morgan has upgraded Forest Laboratories FRX from Neutral to Overweight and has raised the price target from $38 to $41 as a favorable risk/reward profile is being witnessed for the stock.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: UpgradesPrice TargetAnalyst Ratingsforest laboratoriesHealth CareJP MorganPharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in